NERA Economic Consulting
ENTIRE SITE
NERA EXPERTS
EXPERTS
PRACTICE AREAS
ABOUT NERA |
Contact Us
About NERA
MMC Family
GLOBAL LOCATIONS |
CASE & PROJECT EXPERIENCE |
PUBLICATIONS |
Just Published
Newsletters & Briefs
Publications Search
EVENTS & NEWS |
Events
Speakers' Bureau
Continuing Legal Education
Press Releases
NERA in the News
Media Kit
CAREERS
Home
>
Experts
>
Dr. Richard Rozek
> View All
|
More
< Back to Bio
All Publications for Dr. Richard Rozek
Switching Pharmaceutical Products from Prescription to Over-the-Counter: The Debate in the US
Published Article
2012-12-01
By Dr. Richard Rozek
Economics as a Guide to Developing Public Policies for Biosimilar Pharmaceutical Products
Published Article
2012-11-01
By Dr. Richard Rozek
An Economic Perspective on Small and Large Molecule Pharmaceutical Technologies (Una perspectiva economica sobre las tecnologias farmaceuticas de moleculas pequeñas y grandes)
Published Article
2011-08-01
By Dr. Richard Rozek
Risk and Regulatory Factors Affecting Location Decisions by Research-Based Pharmaceutical Companies
Published Article
2011-01-31
By Dr. Richard Rozek
Key Factors in Attracting Internationally Mobile Investments by the Research-Based Pharmaceutical Industry
Report
2007-09-21
By Dr. Richard Rozek et al.
Patent Wars and Authorised Generics in the USA: Assessing the Issues
Published Article
2007-05-01
By Dr. Richard Rozek et al.
The Intellectual Property Debate: Perspectives from Law, Economics and Political Economy
Book
2006-08-01
Contributions by Dr. Richard Rozek
A Market-Based Approach for Tangible Property Transfer Pricing
Published Article
2005-03-16
By Dr. Richard Rozek et al.
Economic Issues Raised in the FDA’s Proposed Rule on Removing the Essential-Use Designation for Albuterol MDIs
Report
2004-08-13
By Dr. Richard Rozek et al.
Using In-country Comparables to Measure the Returns Due Pharmaceutical Marketing and Distribution Affiliates
Published Article
2003-12-01
By Dr. Richard Rozek et al.
1
2
3
Next >